Spending-bill provision won't protect biotech firms like critics say

04/9/2013 | Bloomberg

The hysteria over a biotech crop provision signed into law last month has no basis because there's no truth to critics' claims about the law, Bloomberg View columnist Ramesh Ponnuru writes. The law's real impact is modest, and it would permit farmers to continue using products that are safe in case of frivolous lawsuits, Ponnuru writes.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Director, Antibiotics and Innovation Project
The Pew Charitable Trusts
Washington, DC
Group Health Cooperative
Group Health Cooperative
Seattle, WA
PRINCIPAL ENGINEER , SERVICE - 14000009CP
Abbott
Chicago, IL
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)